Healthcare PCP/ PPI funded projects
Project status update: scope, phases, timings and deadlines
|ACRONYM||TITLE||ABSTRACT||PCP PHASES||DEADLINES (Opening/closing times)||LINK TO TENDER DOCUMENTS||DURATION|
OFFERS PER PHASE
|OMC||PHASE 1||PHASE 2||PHASE 3|
|RELIEF||RECOVERING LIFE WELLBEING THROUGH PAIN SELF-MANAGEMENT|
TECHNIQUES INVOLVING ICTs GA -689476, PCP http://relief-chronicpain.eu/
|RELIEF aims to link European health procurers in order to create the innovative and sustainable solutions that will improve chronic pain control/relieve through ITC self-management techniques.|
Chronic pain diseases is costing to healthcare systems annually over €300bn in Europe; 1.5%-3% of GDP.. This has been identified as important drivers of avoidable healthcare costs. However, it has been estimated that nine-tenths of the burden of pain may fall on the broader society. Even small increases in the effectiveness of pain management reap large economic rewards.
More than half of patients with acute or chronic pain are not well treated even though the existing therapeutic options have confirmed effective results. eHealth solutions must achieve greater comparability between systems, patients and protocols, so as to reach more effective and efficient procedures.
At present, there is a wide range of high-tech devices aimed at treating pain in its many facets and complexity. But it is still necessary to cover the gap between Research and Commercialization of new products and devices.
RELIEF will foster and accelerate the access to market for innovative solutions, while respecting the public procurement directives. The project will contribute to boost innovative tools that empower the patient to self-manage current and future pains.
|PHASE A. Solution design: IDENTIFICATION OF INNOVATIVE AND COST-EFFECTIVE SOLUTIONS(20% PCP budget; 6 months)|
This phase is a feasibility study of the selected technologies and proposals PHASE B. Prototype development (35% PCP budget; 6 months) PHASE C. Pre-commercial development; field test (45% PCP budget; 12 months)
|€1.890.000,00||PHASE A - 8 solutions PHASE B- 4 solutions PHASE C -2 solutions||Nov 2016 - Dec 2016||April 2017-Sept 2017||Oct 2017 - March 2018||April 2018 - April 2019||http://relief-chronicpain.eu/tender.html||39||OMC launched; see project website||Workshop OMC, Dec 2016 (Uppsala 9 Dec; Paris 1 Dec; Córdoba 14 Dec)||Patricia Martinez Galisteo European Projects Coordinator BravoSolution Avenida de Manotera 42 1º 28050 Madrid Phone: + 34 91 787 02 29 | M: +34 606 34 94 64 firstname.lastname@example.org||14/11/2016|
|EMPATTICS||Empowering Patients for a BeTTer Information and improvement of the Communication Systems GA-690492 / PCP http://www.empattics.eu||EMPATTICS will study the socio-economic and age dependency factors that affect awareness, uptake and adherence to self-management services. This will define and design a best in class self-management service that provide the educational and informational services that a large population of elderly and chronic patients require to self-manage. The aim of this procurement is to trigger new solutions to be developed and tested to address the following common challenge: to improve the empowerment of chronic patients through supporting the patients ‘adherence. The main technical challenges to be addressed are: new innovative services that will allow increased co- creation and co-operation between health, social care and patients/caregivers that will increase the patient´s adoption and adherence using ICT self-care technologies and enhance professionals in the use of decision support systems.|
Tools that can be created into the daily routines of patients and health and care professionals to deliver standardised care across a large population of chronic and elderly patients. This will include the technology requirements and use cases for sharing care plans between professionals and patients as well as the scope and depth of integration between new productivity and care coordination toolsets and current EMR recording software.
|1st PHASE. Solution design: Feasibility study: Technology description, first solution design and organizational plan. Cost benefit analysis. Impatct analysis on the patients and eHealth System (9% PCP budget; 6 months) 2nd PHASE. Prototyping: Prototype. Cost-benefit analysis. Limited production and testing plan (36% PCP budget; 9 months) 3rd PHASE. Validation and Testing: Testing and evaluation. Cost-benefits analysis (55% PCP budget; 8 months)||3.500.000€||PHASE A - 10 solutions PHASE B- 5 solutions PHASE C -3 solutions||nov. 2016||June 2017- September 2017||Oct 2017- Jul 2018||Aug 2018 - March 2019||http:// www.empattics.eu||39||Preparing the Common Challenge and the Open Market Consultation||Worshops OMC: November 9th Copenhagen; 15th Santiago; 18th Zaragoza; 23rd Paris||Susana Fernández Nocelo European Projects Coordinator ACIS, Axencia de Coñecemento en Saúde Avda. Fernando de Casas Novoa nº 37 Portal A-B 1º andar 15707 Santiago de Compostela A Coruña - Spain Phone: + 34 881 54 00 54 M: +34 646 40 48 91 email@example.com||14/11/2016|
|NYMPHA-MD||Next Generation Mobile Platforms for HeAlth, in Mental Disorders||NYMPHA project focuses on the implementation of a Pre-Commercial Procurement of mobile ehealth services for supporting physicians and patients in the treatment of bipolar disorder through continuous patients monitoring in order to dynamically support illness management and potentially identify early deviations in mood and attitudes suggesting the onset of a crisis. Such innovative approach in treatment will allow the early intervention of professionals and a personalized and continuous feed-back to patients about warning signs and indications for referral to professionals and self-management. From this point of view, access to interactive tools able to deliver psycho-education and self-help sessions according to standardized and effective models will be available. The monitoring model of such type of approach would be based on a portable data acquisition system able to obtain continuous objective measurements of patients behavior related to their clinical state, also giving feed-backs and visualizing data to patients, thus enhancing patients’ awareness and empowering attitude and supporting their self-management, with the support of ICT.||“PHASE ONE” (solution design) has the object of PLANNING INNOVATIVE TECHNOLOGICAL SOLUTIONS AND PRODUCING THE RELATED FEASIBILITY STUDY (12% PCP budget, 2 months)|
“PHASE TWO” (prototype development) has the scope of DEVELOPING AND INTEGRATING THE PROTOTYPE FOR THE INNOVATIVE SOLUTION PROPOSED. The phase 2 bid will involve presenting a development programme for the prototype, including the design and technical specifications for this, and a financial-business plan. (38% PCP budget, 5 months)
“PHASE THREE” (original development of a limited volume of first products or services in the form of a test series) has the scope of carrying out INITIAL DEVELOPMENT OF A LIMITED QUANTITY OF PROTOTYPE PRODUCTS/SERVICES IN THE FORM OF A TEST SERIES. The phase 3 bid will involve presenting a programme of experimentation in a real environment for a limited number of prototypes. (50% PCP budget, 4 months)
|€1.600.000,00||PHASE A - 4 solutions PHASE B- 3 solutions PHASE C -2 solutions||June - September 2015||August - December 2015 (as published originally in Call for Tender)|
ACTUAL -May - July 2016
|April-June 2016 (as published originally in Call for Tender)|
ACTUAL Dec'16 - March'17
|December 2016 - January 2017 (as published originally in Call for Tender)|
ACTUAL June - Sept 2017
|www.appalti.provincia.tn.it/bandiappalti/pagina11571.html http://www.nympha-md-project.eu/call-tender/open-call||42||Awarded Phase 1|
Preparing Phase 2
|Launch of Phase 2 (dates to be confirmed)||Dr. Oscar Mayora|
CREATE-NET Research Center
Via alla Cascata 56/D - Povo
38123 Trento (Italy)
Phone (+39) 0461 408400 ext. 2475
|SILVER||Supporting Independent Living for the Elderly through Robotics GA287609||SILVER (Supporting Independent LiVing for the Elderly through Robotics) is a development project funded by the European Commission under the Seventh Framework Programme for research and technological development (FP7).|
The SILVER project searches for new technologies to assist elderly people in their everyday lives. By the use of robotics or other related technologies, the elderly can continue independent living at home even if they have physical or cognitive disabilities.
The new technologies and solutions are sought by using a Pre-Commercial Procurement (PCP) process. In Europe, the PCP has so far been an under-utilized tool for promoting innovation. One of the aims of this project is to demonstrate the effectiveness of this approach to address societal and governmental needs.
|SOLUTION DESIGNDuration 6 months, up to 8 companies, budget up to 350,000 EUR PROTOTYPE DEVELOPMENTDuration 12 months, up to 4 companies, budget up to 720,000 EUR PRECOMMERCIAL SMALL SCALE PRODUCT/SERVICE DEVELOPMENTDuration 12 months, up to 3 companies, budget up to 1,080,000 EUR||€2.150.000,00||PHASE A - 7 solutions PHASE B- 3 solutions PHASE C - 1 solution||2012||March 2013 -June 2013||May 2014 - May 2015||July 2015 - August 2016||http://www.silverpcp.eu/||56||Phase 3 Testing until August 2016||Final Conference & Workshop completed||Stephen Browning Innovate UK firstname.lastname@example.org +44 1793 442700||14/11/2016|
|MAGIC||MobileAssistance forGroups &Individuals within theCommunity – Stroke Rehabilitation Grant Agreement No 687228 http://magic-pcp.eu||The MAGIC Buyers Group is aiming to use novel applications of technology, commissioned through PCP, to empower patients and enhance the intervention of Rehabilitation Therapy in order to Maximise the level of functional independence at six month post stroke as measured by the Modified Rankin Score and Bartel Index.||In Phase 1, 7 suppliers will be afforded the opportunity to work with Practitioners in Italy and Northern Ireland to develop their idea. At the end of Phase 1 a closed competitive call will appoint 4 of the 7 suppliers enabling them to move into a phase of prototyping. During this Phase suppliers will work with local public healthcare services to refine design and apply for research governance and ethical approval in preparation for the final phase. In Phase 3, following a further closed competitive process 3 of the 4 Phase 2 suppliers will be invited to deploy their technology to scale. The field trials will be conduced within the Buyer's Group regions of Italy and Northern Ireland.||3.632.800,00€||Phase 1= 7x€60k Phase 2= 4x €105.7k Phase 3= 3x €930k||01:06:16 to 31:07:16||01:02:17 to 31:07:17 (TBC)||01:10:17 to 31:03:18 (TBC)||01:07:18 to 31:12:19 (TBC)||The website for MAGIC ishttp://magic-pcp.eu. However, the entire tender documents will not be published on the website as the application will be through an electronic procurement portal. Therefore, for registration of supplier & then once ‘call’ is live all associated MAGIC PCP documents can be downloaded fromhttps://etendersni.gov.uk||52||Phase Zero is now complete and R&D Suppliers need to be appointed so that Phase 1 can commense.||Call for Tender is about to be issued in October 2016 and will stay open for approximately 2-months||Julie-Ann Walkden, SBRI Executive, MAGIC-PCP Co-Ordinator, LEAR for BSO, Business Services Organisation, Franklin Street, Belfast, BT2 8DQ. Northern Ireland Tel:- 00447979365939 email@example.com and firstname.lastname@example.org||14/11/2016|
|DECIPHER||Distributed European Community Individual Patient Healthcare Electronic Record), GA-288028, PCP, http://decipherpcp.eu/||The DECIPHER project is challenging the industry to develop a mobile health solutions referred as DECIPHER Service.|
The DECIPHER Service is expected to address the challenges described below:
• An up-to-date view of a person’s health data connecting to the Personal Health Record Systems, which are already existing or being developed in different countries
• Support to treatment management (therapeutic and medication)
• Connection with country-specific health-data repositories
• Need for automatic language translation.
• Support for cross-border health in case of unplanned care
• Where available, also Patient Access services included in the epSOS infrastructure may be used to access health records.
• Necessary functionalities in order to connect with these country-specific services and exchange information with them as required by the addressed use cases.
|• Phase 0: Initial Selection.- Any Bidder shall be entitled to submit a preliminary innovative solution, for which shall receive no payment (no budget nor payments at this stage). |
• Phase 1: Solution Design Selection. A maximum of 9 Bidders awarded with the Phase 1 shall be entitled to submit a final design for an innovative solution, for which each Bidder shall receive a maximum payment of 25.000 EUR (VAT excluded).
• Phase 2: Prototype Development Selection.- A maximum of 6 Bidders awarded with the Phase 2 shall be entitled to develop prototypes on the basis of the final innovative solutions selected at the end of Phase 1, for which each Bidder shall receive a maximum payment of 52.500 EUR (VAT excluded).
• Phase 3: Proof of Concept.- A maximum of 3 Bidders awarded with the Phase 3 shall be entitled to produce and test a small scale products on the basis of the prototypes finally selected at the end of Phase 2, for which each Bidder shall receive a maximum payment of 120.000 EUR (VAT excluded).
|€900.000,00||Phase 1 - 9 solutions|
Phase 2 - 6 solutions
Phase 3 - 3 solutions
|June 2013 - Nov 2013||april 2015 - jul 2015||mar 2016 - sept 2016||Nov 2016 - Mar 2017||http://decipherpcp.eu/call-tender||50||Phase 2||EXPLOIT PCP! Webinar on October the 26th||Jean Patrick Mathieu|
EU project Manager
Roc Boronat, 81 2ª planta
Tel: +34 93 551 34 77